A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Miller, David H, Khan, Omar A, Sheremata, William A, Blumhardt, Lance D, Rice, George P.A, Libonati, Michele A, Willmer-Hulme, Allison J, Dalton, Catherine M, Miszkiel, Katherine A, O'Connor, Paul W
Published in The New England journal of medicine (02.01.2003)
Published in The New England journal of medicine (02.01.2003)
Get full text
Journal Article
LB-S&T-04 PROSPECTIVE, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED, MULTINATIONAL, PHASE 3 CLINICAL TRIAL OF THE PORE FORMING PROTEIN PRX302 FOR TARGETED TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
Roehrborn, Claus, Bruskewitz, Reginald, Yocum, Richard, Hulme, Allison, Gittelman, Marc
Published in The Journal of urology (01.04.2016)
Published in The Journal of urology (01.04.2016)
Get full text
Journal Article
MP70-15 INTRA-PROSTATIC PRX302 FOCAL THERAPY IN TREATING CLINICALLY SIGNIFICANT LOW-INTERMEDIATE PROSTATE CANCER: AN OPEN LABEL, PROOF-OF-CONCEPT STUDY
Bass, Edward, Shanmugabavan, Yaalini, Hulme, Allison, Freeman, Alex, Brew-Graves, Chris, Potyka, Ingrid, Ramachandran, Navin, Emberton, Mark, Ahmed, Hashim
Published in The Journal of urology (01.04.2017)
Published in The Journal of urology (01.04.2017)
Get full text
Journal Article